Pediatric Endocrinology Diabetes and Metabolism

Mukopolisacharydoza typu IIIC rozpoznana w wieku 12 lat – dlaczego tak późno?

Patryk Lipiński 1, 2
,
Rafał Płoski 3
,
Agnieszka Ługowska 4

  1. Institute of Clinical Sciences, Maria Skłodowska-Curie Medical Academy, Warsaw, Poland

  2. Third Department of Pediatrics, Center of Postgraduate Medical Education, Dziekanów Leśny, Poland

  3. Department of Genetics, Institute of Psychiatry and Neurology, Warsaw, Poland

  4. Department of Medical Genetics, Medical University of Warsaw, Poland

Pediatr Endocrinol Diabetes Metab 2026; 32 (3):

DOI: https://doi.org/10.5114/pedm.2026.163913
Data publikacji online: 2026/08/14
Plik artykułu
0364_Mucopolysaccharidosis.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Wiśniewska K, Wolski J, Gaffke L, et al. Misdiagnosis in mucopolysaccharidoses. J Appl Genet 2022; 63: 475–495.
  2. Jakobkiewicz-Banecka J, Gabig-Ciminska M, Kloska A, et al. Glycosaminoglycans and mucopolysaccharidosis type III. Front Biosci (Landmark Ed) 2016; 21: 1393–1409. doi: 10.2741/4463.
  3. Spahiu L, Behluli E, Peterlin B, et al. Mucopolysaccharidosis III: Molecular basis and treatment. Mukopolisacharydoza III: podstawy molekularne i leczenie. Pediatr Endocrinol Diabetes Metab 2021; 27: 201–208. doi: 10.5114/pedm.2021.109270.
  4. Muschol N, Giugliani R, Jones SA, et al. Sanfilippo syndrome: consensus guidelines for clinical care. Orphanet J Rare Dis 2022; 17: 391. doi: 10.1186/s13023-022-02484-6.
  5. Jurecka A, Ługowska A, Golda A, et al. Prevalence rates of mucopolysaccharidoses in Poland. J Appl Genet 2015; 56: 205–210. doi: 10.1007/s13353-014-0262-5.
  6. Wijburg FA, Węgrzyn G, Burton BK, Tylki-Szymańska A. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder. Acta Paediatr 2013; 102: 462–470. doi: 10.1111/apa.12169.
  7. Rintz E, Banacki M, Ziemian M, et al. Causes of death in mucopolysaccharidoses. Mol Genet Metab 2024; 142: 108507. doi: 10.1016/j.ymgme.2024.108507.
  8. Filocamo M, Tomanin R, Bertola F, Morrone A. Biochemical and molecular analysis in mucopolysaccharidoses: what a paediatrician must know. Ital J Pediatr 2018; 44 (Suppl 2): 129. doi: 10.1186/s13052-018-0553-2.
  9. Bodamer OA, Giugliani R, Wood T. The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): a changing landscape. Mol Genet Metab 2014; 113: 34–41. doi: 10.1016/j.ymgme.2014.07.013.
ZGŁASZANIE PRAC
Udostępnij
without publication fees
Zintergrowane z
integrated with publons
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications